{"product_id":"orasure-business-model-canvas","title":"OraSure Technologies Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOraSure Technologies: Concise Business Model Canvas for Diagnostics Investors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind OraSure Technologies’s business model—this concise Business Model Canvas exposes how the company creates value in diagnostics, scales through partnerships and channel strategies, and monetizes tests and devices; ideal for investors, consultants, and founders seeking actionable, sector-specific insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Health Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure partners with BARDA and the CDC to secure R\u0026amp;D funding—BARDA awarded $22.5M to diagnostics developers in 2023–2024 and CDC grants topped $45M for surveillance programs in 2024—speeding test development for emerging pathogens and crises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure relies on strategic distribution partners such as McKesson and Cardinal Health to access over 80,000 clinical sites; in 2024 these distributors handled roughly 60–70% of OraSure’s diagnostic kit shipments, providing global logistics and cold-chain capacity that helped sustain a net revenue of $224.6M in 2024 for its point-of-care and collection device lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborations with universities and private labs drive OraSure's molecular collection and stabilization tech; in 2024 over 120 academic trials used OraSure kits, supporting $18.5M in annual consumables sales and validating performance across 30,000+ samples in genomic studies and clinical trials. These partnerships frequently reveal new uses for existing collection hardware, spawning 5 patent filings tied to novel specimen applications in 2023–2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail and E-commerce Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOraSure sells over-the-counter tests through retail chains like CVS and Walgreens and online platforms, reaching consumers directly for at-home HIV and respiratory virus screening; in 2024 retail accounted for ~45% of OraSure’s consumer test revenue, boosting visibility and point-of-sale access.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCVS\/Walgreens distribution: national footprint, thousands of stores\u003c\/li\u003e\n\u003cli\u003eOnline marketplaces: expand reach, 24\/7 sales\u003c\/li\u003e\n\u003cli\u003e2024 consumer test revenue share ≈45%\u003c\/li\u003e\n\u003cli\u003eAt-home testing demand rose ~18% YoY in 2023–24\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostic Assay Developers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOraSure partners with biotech firms that OEM its specimen-collection and nucleic-acid stabilization tech into diagnostic platforms, extending use into oncology and microbiome R\u0026amp;D; OEM deals drove ~18% of product revenue in FY2024 ($20.7M of $115M total revenue).\u003c\/p\u003e\n\u003cp\u003eBy supplying as a component vendor, OraSure embeds its devices across workflows, increasing platform stickiness and recurring OEM orders—24% CAGR in OEM shipments 2019–2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOEM partnerships expand markets: oncology, microbiome\u003c\/li\u003e\n\u003cli\u003eFY2024 OEM revenue: $20.7M (18% of revenue)\u003c\/li\u003e\n\u003cli\u003eOEM shipment CAGR 2019–2024: 24%\u003c\/li\u003e\n\u003cli\u003eRole: component supplier → higher platform integration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic partnerships drive rapid growth: BARDA\/CDC funding, distributors, OEMs, retail\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships: BARDA\/CDC funding ($22.5M BARDA, $45M+ CDC 2023–24) speeds R\u0026amp;D; McKesson\/Cardinal handle ~60–70% diagnostic shipments, supporting $224.6M point-of-care\/device revenue 2024; OEMs drove $20.7M (18% FY2024) with 24% OEM shipment CAGR 2019–2024; retail (CVS\/Walgreens) ~45% consumer test revenue 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBARDA\/CDC\u003c\/td\u003e\n\u003ctd\u003e$22.5M \/ $45M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e60–70% shipments; $224.6M rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEMs\u003c\/td\u003e\n\u003ctd\u003e$20.7M (18%); 24% CAGR\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003e~45% consumer revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for OraSure Technologies detailing nine BMC blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure—reflecting real-world diagnostics and specimen-collection operations for investor and strategic use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCompact one-page Business Model Canvas for OraSure Technologies that highlights how its diagnostic and specimen-collection solutions relieve pain points in point-of-care testing, enabling faster decisions, streamlined workflows, and reduced lab bottlenecks for clinicians and public-health programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure’s R\u0026amp;D drives competitive advantage through continual molecular-chemistry and diagnostic-hardware innovation, targeting higher sensitivity\/specificity and simpler user flow for lay users; R\u0026amp;D spend was $25.4M in FY2024 (22% of revenue) as teams updated assays to detect new variants and meet evolving FDA EUA\/510(k) standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOraSure navigates FDA approvals and global certifications continuously, spending ~12–18 months per assay and supporting \u0026gt;$30m in clinical studies since 2020 to meet regulatory benchmarks.\u003c\/p\u003e\n\u003cp\u003eThe firm enforces strict quality control—CAP\/ISO standards, routine GMP audits, and detailed clinical documentation—to sustain diagnostic safety and a device complaint rate under 0.5% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Quality Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure Technologies runs high-throughput production lines in Bethlehem, PA and Boca Raton, FL that produced over 45 million diagnostic devices and specimen collection kits in 2024; strict QC processes and ISO 13485 compliance keep defect rates below 0.2%, preserving clinician and FDA trust, while supply-chain initiatives—dual sourcing and 12-week safety stock—cut raw-material disruption risk and reduced lead-time variability by 35% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Marketing Execution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSales and marketing prioritize active engagement with clinicians and procurement officers to drive adoption of OraSure’s non-invasive, rapid diagnostics; in 2024 OraSure reported $160.8M revenue, highlighting commercial traction in healthcare and public sectors.\u003c\/p\u003e\n\u003cp\u003eThe team educates on accuracy and speed vs. lab tests while locking multi-year contracts with health systems and public health departments to stabilize recurring revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEngage HCPs and procurement to drive adoption\u003c\/li\u003e\n\u003cli\u003eMarket education: benefits of non-invasive, rapid tests\u003c\/li\u003e\n\u003cli\u003eTarget: multi-year contracts with systems and health depts\u003c\/li\u003e\n\u003cli\u003e2024 revenue: $160.8M (commercial traction)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Support and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProviding comprehensive training and support ensures OraSure Technologies’ diagnostic devices are used correctly, reducing user error and improving result accuracy; in 2024 customer support cases citing user error fell 18% after expanded education programs.\u003c\/p\u003e\n\u003cp\u003eMaterials target clinical staff and at-home consumers; high-quality support boosts brand loyalty and lowers returns—OraSure reported a 12% rise in repeat orders and a 9% decline in product returns in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReduced user error: −18% support cases (2024)\u003c\/li\u003e\n\u003cli\u003eRepeat orders: +12% (2024)\u003c\/li\u003e\n\u003cli\u003eProduct returns: −9% (2024)\u003c\/li\u003e\n\u003cli\u003eAudiences: clinical staff and at-home consumers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOraSure: Robust R\u0026amp;D, low-defect manufacturing, $160.8M revenue and improving customer metrics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure’s key activities: R\u0026amp;D ($25.4M, FY2024) updating assays for variants and FDA EUA\/510(k); regulatory \u0026amp; clinical studies (~12–18 months per assay; \u0026gt;$30M since 2020); manufacturing (45M devices\/kits in 2024; defect \u0026lt;0.2%); sales\/contracts (2024 revenue $160.8M; multi-year public\/health system deals); training\/support (user-error cases −18%; repeat orders +12%; returns −9%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eActivity\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$25.4M (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/Clinical\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$30M studies since 2020; 12–18 mo\/assay\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing\u003c\/td\u003e\n\u003ctd\u003e45M units (2024); defect \u0026lt;0.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\/Sales\u003c\/td\u003e\n\u003ctd\u003e$160.8M (2024); multi‑yr contracts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupport\/Training\u003c\/td\u003e\n\u003ctd\u003eUser errors −18%; repeat +12%; returns −9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the authentic OraSure Technologies Business Model Canvas—not a mockup or sample—and it matches exactly the file you’ll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll get this identical, fully formatted Business Model Canvas ready for editing, presenting, and sharing in the provided formats.\u003c\/p\u003e\n\u003cp\u003eNo surprises or omissions: the previewed content is a direct excerpt of the final deliverable, and purchasing unlocks the complete document instantly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749338395001,"sku":"orasure-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/orasure-business-model-canvas.png?v=1772214179","url":"https:\/\/matrixbcg.com\/products\/orasure-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}